Rhelixa
A leading company in epigenome analysis.
Launch date
Employees
Market cap
-
Enterprise valuation
€11—16m (Dealroom.co estimates Aug 2024.)
Tokyo Japan (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | JPY10.0m | Seed | |
N/A | Early VC | ||
$2.2m | Early VC | ||
* | JPY98.0m | Debt | |
* | JPY392m | Series B | |
| Total Funding | €4.9m | ||
Related Content
Recent News about Rhelixa
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.